OPTIMISING RADIOTHERAPY DOSE COMBINED WITH CHEMOTHERAPY FOR ANAL CANCER - THE DEVELOPMENT OF THREE CLINICAL TRIALS (INCLUDING THE SURGICALLY-BASED ACT 3) ACROSS THE LOCO-REGIONAL RISK SPECTRUM (PLATO TRIAL).

A. Renehan; R. Muirhead; L. McParland; D. Gilbert; R. Adams; M. Harrison; M. Hawkins; D. Sebag-Montefiore

OPTIMISING RADIOTHERAPY DOSE COMBINED WITH CHEMOTHERAPY FOR ANAL CANCER - THE DEVELOPMENT OF THREE CLINICAL TRIALS (INCLUDING THE SURGICALLY-BASED ACT 3) ACROSS THE LOCO-REGIONAL RISK SPECTRUM (PLATO TRIAL).

A. Renehan, R. Muirhead, L. McParland, D. Gilbert, R. Adams, M. Harrison, M. Hawkins, D. Sebag-Montefiore

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	E325-E326
Journal	Diseases of the Colon and Rectum
Volume	60
Issue number	6
Publication status	Published - Jun 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Renehan, A., Muirhead, R., McParland, L., Gilbert, D., Adams, R., Harrison, M., Hawkins, M., & Sebag-Montefiore, D. (2017). OPTIMISING RADIOTHERAPY DOSE COMBINED WITH CHEMOTHERAPY FOR ANAL CANCER - THE DEVELOPMENT OF THREE CLINICAL TRIALS (INCLUDING THE SURGICALLY-BASED ACT 3) ACROSS THE LOCO-REGIONAL RISK SPECTRUM (PLATO TRIAL). Diseases of the Colon and Rectum, 60(6), E325-E326.

@article{21b21df990e34aec886c7ca9aabc3300,

title = "OPTIMISING RADIOTHERAPY DOSE COMBINED WITH CHEMOTHERAPY FOR ANAL CANCER - THE DEVELOPMENT OF THREE CLINICAL TRIALS (INCLUDING THE SURGICALLY-BASED ACT 3) ACROSS THE LOCO-REGIONAL RISK SPECTRUM (PLATO TRIAL).",

author = "A. Renehan and R. Muirhead and L. McParland and D. Gilbert and R. Adams and M. Harrison and M. Hawkins and D. Sebag-Montefiore",

year = "2017",

month = jun,

language = "English",

volume = "60",

pages = "E325--E326",

journal = "Diseases of the Colon and Rectum",

issn = "0012-3706",

publisher = "Lippincott Williams & Wilkins",

number = "6",

}

Renehan, A, Muirhead, R, McParland, L, Gilbert, D, Adams, R, Harrison, M, Hawkins, M & Sebag-Montefiore, D 2017, 'OPTIMISING RADIOTHERAPY DOSE COMBINED WITH CHEMOTHERAPY FOR ANAL CANCER - THE DEVELOPMENT OF THREE CLINICAL TRIALS (INCLUDING THE SURGICALLY-BASED ACT 3) ACROSS THE LOCO-REGIONAL RISK SPECTRUM (PLATO TRIAL).', Diseases of the Colon and Rectum, vol. 60, no. 6, pp. E325-E326.

OPTIMISING RADIOTHERAPY DOSE COMBINED WITH CHEMOTHERAPY FOR ANAL CANCER - THE DEVELOPMENT OF THREE CLINICAL TRIALS (INCLUDING THE SURGICALLY-BASED ACT 3) ACROSS THE LOCO-REGIONAL RISK SPECTRUM (PLATO TRIAL). / Renehan, A.; Muirhead, R.; McParland, L. et al.
In: Diseases of the Colon and Rectum, Vol. 60, No. 6, 06.2017, p. E325-E326.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - OPTIMISING RADIOTHERAPY DOSE COMBINED WITH CHEMOTHERAPY FOR ANAL CANCER - THE DEVELOPMENT OF THREE CLINICAL TRIALS (INCLUDING THE SURGICALLY-BASED ACT 3) ACROSS THE LOCO-REGIONAL RISK SPECTRUM (PLATO TRIAL).

AU - Renehan, A.

AU - Muirhead, R.

AU - McParland, L.

AU - Gilbert, D.

AU - Adams, R.

AU - Harrison, M.

AU - Hawkins, M.

AU - Sebag-Montefiore, D.

PY - 2017/6

Y1 - 2017/6

M3 - Meeting Abstract

SN - 0012-3706

VL - 60

SP - E325-E326

JO - Diseases of the Colon and Rectum

JF - Diseases of the Colon and Rectum

IS - 6

ER -